Assembly Biosciences Inc

-0.07 (-1.75%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)157.82M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.51 Million
Adjusted EPS-$0.75
See more estimates
10-Day MA$4.03
50-Day MA$4.43
200-Day MA$9.90
See more pivots

Assembly Biosciences Inc Stock, NASDAQ:ASMB

331 Oyster Point Boulevard, 4th floor, South San Francisco, California 94080
United States of America
Phone: +1.833.509.4583
Number of Employees: 139


Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.